Kevin G. Leong

4.7k total citations · 1 hit paper
18 papers, 3.1k citations indexed

About

Kevin G. Leong is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin G. Leong has authored 18 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin G. Leong's work include Angiogenesis and VEGF in Cancer (4 papers), Developmental Biology and Gene Regulation (4 papers) and Cancer Cells and Metastasis (3 papers). Kevin G. Leong is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Developmental Biology and Gene Regulation (4 papers) and Cancer Cells and Metastasis (3 papers). Kevin G. Leong collaborates with scholars based in United States, Canada and India. Kevin G. Leong's co-authors include Aly Karsan, Wei‐Qiang Gao, Brian Biehs, Frédéric J. de Sauvage, Søren Warming, Linda Rangell, Hua Tian, Ophir D. Klein, Leisa Johnson and Bu-Er Wang and has published in prestigious journals such as Nature, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Kevin G. Leong

18 papers receiving 3.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable

2011 904 citations Hua Tian, Brian Biehs et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin G. Leong United States	15	1.9k	1.3k	638	544	384	18	3.1k
Chizu Tanikawa Japan	28	1.9k 1.0×	1.2k 0.9×	581 0.9×	436 0.8×	254 0.7×	57	3.1k
Inna Gitelman Israel	12	2.6k 1.4×	1.9k 1.5×	998 1.6×	452 0.8×	416 1.1×	20	3.9k
Kaustubh Datta United States	33	2.0k 1.1×	827 0.6×	787 1.2×	447 0.8×	192 0.5×	75	3.1k
Koh‐ichi Nakashiro Japan	34	1.7k 0.9×	1.4k 1.1×	802 1.3×	494 0.9×	169 0.4×	127	3.3k
Michel M. Ouellette United States	29	2.0k 1.0×	1.4k 1.1×	488 0.8×	232 0.4×	209 0.5×	54	3.5k
Kou‐Juey Wu Taiwan	30	2.5k 1.3×	661 0.5×	894 1.4×	413 0.8×	250 0.7×	59	3.6k
Zhenhe Suo Norway	32	1.8k 0.9×	1.3k 1.0×	872 1.4×	447 0.8×	129 0.3×	107	3.1k
Enrica Martinelli Italy	23	1.5k 0.8×	1.0k 0.8×	502 0.8×	249 0.5×	322 0.8×	44	3.1k
Shunyou Wang United States	17	2.7k 1.4×	881 0.7×	786 1.2×	1.4k 2.6×	364 0.9×	27	3.9k
Daniel J. Murphy United Kingdom	22	2.2k 1.1×	843 0.7×	645 1.0×	306 0.6×	164 0.4×	43	3.0k

Countries citing papers authored by Kevin G. Leong

Since Specialization

Citations

This map shows the geographic impact of Kevin G. Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin G. Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin G. Leong more than expected).

Fields of papers citing papers by Kevin G. Leong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin G. Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin G. Leong. The network helps show where Kevin G. Leong may publish in the future.

Co-authorship network of co-authors of Kevin G. Leong

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin G. Leong. A scholar is included among the top collaborators of Kevin G. Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin G. Leong. Kevin G. Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Leong, Kevin G., et al.. (2024). The future of vascular surgery and the general surgery resident. 3. 100152–100152. 1 indexed citations

Hsu, Jeff, Jeffrey Serrill, Sharon Wu, et al.. (2022). Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER. Molecular Cancer Therapeutics. 22(2). 179–191. 12 indexed citations

Leong, Kevin G., et al.. (2019). Atrial tumor thrombus. JAAPA. 32(2). 23–26. 3 indexed citations

Enquist, Ida, Zinaida Good, Adrian M. Jubb, et al.. (2014). Lymph node-independent liver metastasis in a model of metastatic colorectal cancer. Nature Communications. 5(1). 3530–3530. 53 indexed citations

Sun, Yuting, Bu-Er Wang, Kevin G. Leong, et al.. (2011). Androgen Deprivation Causes Epithelial–Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy. Cancer Research. 72(2). 527–536. 287 indexed citations

Vitari, Alberto C., Kevin G. Leong, Kim Newton, et al.. (2011). COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 474(7351). 403–406. 138 indexed citations

Tian, Hua, Brian Biehs, Søren Warming, et al.. (2011). A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 478(7368). 255–259. 904 indexed citations breakdown →

Bagri, Anil, Hosein Kouros‐Mehr, Kevin G. Leong, & Gregory D. Plowman. (2010). Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale. Trends in Molecular Medicine. 16(3). 122–132. 64 indexed citations

Leong, Kevin G. & Wei‐Qiang Gao. (2008). The Notch pathway in prostate development and cancer. Differentiation. 76(6). 699–716. 111 indexed citations

10.

Leong, Kevin G., Bu-Er Wang, Leisa Johnson, & Wei‐Qiang Gao. (2008). Generation of a prostate from a single adult stem cell. Nature. 456(7223). 804–808. 332 indexed citations

11.

Leong, Kevin G., Kyle Niessen, Iva Kulić, et al.. (2007). Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. The Journal of Experimental Medicine. 204(12). 2935–2948. 389 indexed citations

12.

Leong, Kevin G., Kyle Niessen, Iva Kulić, et al.. (2007). Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. The Journal of Cell Biology. 179(4). i6–i6. 16 indexed citations

13.

Leong, Kevin G. & Aly Karsan. (2005). Recent insights into the role of Notch signaling in tumorigenesis. Blood. 107(6). 2223–2233. 409 indexed citations

14.

Pollet, Ingrid L., et al.. (2003). Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-κB and c-Jun N-terminal kinase. Blood. 102(5). 1740–1742. 83 indexed citations

15.

Leong, Kevin G., Linheng Li, Michela Noseda, et al.. (2002). Activated Notch4 Inhibits Angiogenesis: Role of β1-Integrin Activation. Molecular and Cellular Biology. 22(8). 2830–2841. 143 indexed citations

16.

Leong, Kevin G., et al.. (2002). Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia. American Journal of Hematology. 70(1). 22–30. 34 indexed citations

17.

Roskelley, Calvin D., David E. Williams, Lianne M. McHardy, et al.. (2001). Inhibition of tumor cell invasion and angiogenesis by motuporamines.. PubMed. 61(18). 6788–94. 60 indexed citations

18.

Leong, Kevin G. & Aly Karsan. (2000). Signaling pathways mediated by tumor necrosis factor alpha.. PubMed. 15(4). 1303–25. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact